Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-18-057056

Executive VP, Drug Development sold 494 shares at $30.62 ($15,125)

  • Executive VP, Drug Development acquired 494 shares (other)

From the SEC's structured data for this filing

Trades in this filing

MANHARD KIMBERLY · Executive VP, Drug Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-10-31 Other acquisition : show line 1 in the form +494 $23.60 $11,656 494 D
2018-11-02 Sale : show line 2 in the form −494 $30.62 $15,125 0 D
Open-market sales · 494 sh · avg $30.62 · $15,125
Loading xslF345X03/doc4.xml…